Nifuroxazide mitigates cholestatic liver injury by synergistic inhibition of Il-6/Β-catenin signaling and enhancement of BSEP and MDRP2 expression
2012 ◽
Vol 23
(3)
◽
pp. 252-264
◽
2010 ◽
Vol 161
(5)
◽
pp. 1111-1121
◽
Keyword(s):
2018 ◽
Vol 392
(1)
◽
pp. 37-43
◽
Keyword(s):